Treatment of human umbilical cord-derived mesenchymal stem cells for hepatitis B virus-associated decompensated liver cirrhosis: A clinical trial
hUC-MSCs can be considered a safe treatment for patients with decompensated liver cirrhosis associated with HBV. However, larger-scale randomized controlled trials are needed to prove its therapeutic effect.
Authors
- Hua-Ni Zhang
- Zhiyong Yang (ORCID: https://orcid.org/0000-0002-6079-6763)
- Meng-Jing Hu (ORCID: https://orcid.org/0009-0005-2465-2681)
- Bo Liao (ORCID: https://orcid.org/0000-0001-9770-5565)
- Zihui Yu
- Zhen Li (ORCID: https://orcid.org/0000-0002-9101-0364)
- Lijun Li (ORCID: https://orcid.org/0000-0002-1656-5546)
- Kun Li (ORCID: https://orcid.org/0000-0001-5469-6240)
- Jing Chen (ORCID: https://orcid.org/0000-0002-3297-9183)
- Yi Li (ORCID: https://orcid.org/0000-0002-8876-0041)
- Lu Yu (ORCID: https://orcid.org/0000-0002-2057-8841)
- Yating Wang (ORCID: https://orcid.org/0000-0001-7549-2415)
- Yan Ma (ORCID: https://orcid.org/0000-0002-8548-8812)
- Xian Qin (ORCID: https://orcid.org/0000-0002-7736-2187)
- Yufeng Yuan
- Liu-Fang Wu
- Li Du
Institutions
- Hubei University of Medicine (CN)
- Wuhan University (CN)
- Zhongnan Hospital of Wuhan University (CN)
- People's Hospital of Shiyan (CN)
Publication Details
- Journal
- World Journal of Gastrointestinal Surgery
- Published
- 2025-09-23
- DOI
- https://doi.org/10.4240/wjgs.v17.i9.109980
- Citations
- 2
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 2.71